Arthneeti

Sarda Proteins Share Price & Earnings Call Analysis

₹120.10-2.00% today
Market cap
₹198 Cr
P/E
78.43
ROE
1.02%
PEG
0.50
Price to sales
13.45
Debt to equity
0.00
Sales growth (5Y)
7.30%
EBITDA margin
-17.69%
Net profit margin
2.78%
Promoter holding
80.47%
Sales (last year)
₹15 Cr

Potential multibaggers · Q2 FY27

Potential multibaggers in Agricultural Food & other Products
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does FRESITA PROTEINS rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Agricultural Food & other Products companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹890 Cr13.7
240%+Up 0–2%₹125 Cr6.8
340%+Flat₹22 Cr9.0
420–40%Up 2%+₹221 Cr15.1
520–40%Up 2%+₹185 Cr17.4
620–40%Up 0–2%₹2,130 Cr27.1

Sign up free to see every company in the sector ranking and track FRESITA PROTEINS.

Pro shows every company guiding 40%+ revenue growth →Full Agricultural Food & other Products ranking

FRESITA PROTEINS announcements

All announcements →

Financials of FRESITA PROTEINS

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of FRESITA PROTEINS

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0.740.240.001.000.060.000.1424.050.0010.954.300.250.65
Expenses +0.770.280.051.030.080.080.0323.950.1011.444.010.370.05
Operating Profit-0.03-0.04-0.05-0.03-0.02-0.080.110.10-0.10-0.490.29-0.120.60
OPM %-4.05%-16.67%-3.00%-33.33%78.57%0.42%-4.47%6.74%-48.00%92.31%
Other Income +0.040.040.040.040.040.000.000.000.000.000.110.000.24
Interest0.000.000.000.000.000.000.000.000.000.000.000.000.00
Depreciation0.000.000.000.000.000.000.000.000.000.000.000.000.00
Profit before tax0.010.00-0.010.010.02-0.080.110.10-0.10-0.490.40-0.120.84
Tax %500.00%0.00%0.00%0.00%0.00%0.00%0.00%20.00%0.00%0.00%0.00%0.00%
Net Profit +-0.040.00-0.010.010.02-0.080.110.10-0.11-0.490.40-0.120.84
EPS in Rs-0.230.00-0.060.060.12-0.460.640.58-0.64-2.842.32-0.700.94

Financials of FRESITA PROTEINS

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5.022.066.185.657.225.4011.3610.765.801.3024.1916.16
Expenses +5.142.186.356.007.335.3111.3810.505.951.4524.1715.87
Operating Profit-0.12-0.12-0.17-0.35-0.110.09-0.020.26-0.15-0.150.020.29
OPM %-2.39%-5.83%-2.75%-6.19%-1.52%1.67%-0.18%2.42%-2.59%-11.54%0.08%1.79%
Other Income +0.800.000.00-0.010.030.080.080.090.160.170.000.35
Interest0.020.030.010.000.000.000.000.000.000.000.000.00
Depreciation0.040.020.010.010.010.000.000.000.000.000.000.00
Profit before tax0.62-0.17-0.19-0.37-0.090.170.060.350.010.020.020.64
Tax %4.84%-5.88%-31.58%-10.81%44.44%82.35%133.33%14.29%500.00%0.00%100.00%0.00%
Net Profit +0.59-0.15-0.13-0.33-0.120.03-0.020.31-0.030.020.010.64
EPS in Rs1.80-0.87-0.75-1.91-0.700.17-0.121.80-0.170.120.060.71
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials of FRESITA PROTEINS

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital2.432.502.502.502.502.502.502.502.502.502.502.50
Reserves0.300.150.02-0.31-0.44-0.41-0.43-0.12-0.15-0.13-0.130.51
Borrowings +0.210.610.200.000.010.000.000.000.000.000.000.16
Other Liabilities +0.200.210.200.130.120.060.070.070.050.070.2883.44
Total Liabilities3.143.472.922.322.192.152.142.452.402.442.6586.61
Fixed Assets +0.100.060.050.030.020.010.010.000.000.000.000.00
CWIP0.000.000.000.000.000.000.000.000.000.000.000.00
Investments0.010.010.010.010.000.000.000.000.000.000.000.00
Other Assets +3.033.402.862.282.172.142.132.452.402.442.6586.61
Total Assets3.143.472.922.322.192.152.142.452.402.442.6586.61

Financials of FRESITA PROTEINS

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-0.72-1.20-0.090.48-0.59-0.05-0.050.10-0.30-0.23-0.11-76.39
Cash from Investing Activity +1.900.200.000.020.110.090.080.090.160.170.000.36
Cash from Financing Activity +-0.130.37-0.42-0.200.01-0.010.000.000.000.000.0383.51
Net Cash Flow1.05-0.63-0.510.30-0.470.030.030.19-0.14-0.07-0.087.48
Free Cash Flow0.73-1.18-0.090.48-0.59-0.04-0.050.10-0.30-0.23-0.11-76.38
CFO/OP525%1,000%53%-134%536%-22%200%38%200%153%-550%-26,341%

Financials of FRESITA PROTEINS

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days13.810.0038.9844.5836.4056.1024.747.120.000.000.0096.44
Inventory Days32.70324.2264.4128.640.000.000.000.000.000.000.000.00
Days Payable0.760.000.610.00
Cash Conversion Cycle45.75324.22102.7873.2236.4056.1024.747.120.000.000.0096.44
Working Capital Days65.44251.60108.0876.2383.92114.9155.9164.45130.27603.6533.95-104.35
ROCE %-5.93%-4.52%-6.02%-14.66%-5.63%8.17%2.88%15.73%0.42%0.85%0.84%23.06%

Continue your research

Others in Agricultural Food & other Products this season

  • A C J K Exports (Q2 FY27)

    1,136 million, up by 70% YoY from Rs. Key results statement takeaways from Amir Chand Jagdish Kumar (Exports) Ltd's Q2 FY27 results statement — and how it ranks

  • The Peria Karamalai Tea (Q2 FY27)

    68.4 lakhs (~6.5% decline) . Key results statement takeaways from The Peria Karamalai Tea & Produce Company Ltd's Q2 FY27 results statement — and how it ranks a

  • Triveni Engineering and Industries (Q2 FY27)

    Q2 FY27 Revenue (Net of Excise Duty):** ₹1,731 crores, up 8.4% YoY from ₹1,597 crores in Q2 FY26. Key investor presentation takeaways from Triveni Engineering a

  • KRBL (Q2 FY27)

    Q2 FY27 consolidated revenue from operations: ₹1,727 crore, up 14% YoY (Page 11). Key investor presentation takeaways from KRBL Ltd's Q2 FY27 investor presentat

Compare:vs Maricovs Tata Consumervs Patanjali Foods